APPLIED BIOCODE TAIWAN LTD.
Update：2026/04/17
Industries
Main Industry
Health Care
Main Product/Service
Providing a multiplex diagnostic platform focused on the research and development of diagnostic reagents, diagnostic instruments, and the manufacturing of technology platforms.
Founded Year
2015
Unified Business No.
42830582
Status
Active
Number of Employees
80
Total Paid-in
Capital
103,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
APPLIED BIOCODE TAIWAN focuses on the design, development, and manufacturing of multiplex diagnostic products marketed globally under the Applied BioCode brand. Its core Barcoded Magnetic Bead (BMB) technology offers up to 4,096 unique digital codes with exceptional decoding accuracy, enabling rapid development of multiplex nucleic acid and protein assays. Its in vitro diagnostic products focus on infectious diseases, including gastrointestinal, respiratory, and COVID-19 testing, with FDA-cleared solutions and ongoing expansion into fungal and antimicrobial resistance detection.
